Gilead Sciences, Inc.

NASDAQ:GILD

92.63 (USD) • At close November 13, 2024
Bedrijfsnaam Gilead Sciences, Inc.
Symbool GILD
Munteenheid USD
Prijs 92.63
Beurswaarde 115,323,423,700
Dividendpercentage 4.46%
52-weken bereik 62.07 - 98.9
Industrie Drug Manufacturers—General
Sector Healthcare
CEO Mr. Daniel P. O'Day
Website https://www.gilead.com

An error occurred while fetching data.

Over Gilead Sciences, Inc.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use,

Vergelijkbare Aandelen

Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc.

ISRG

536.69 USD

Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGN

804.33 USD

Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated

VRTX

494.61 USD

Moderna, Inc. logo

Moderna, Inc.

MRNA

42.14 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

146.17 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

9.03 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

429.82 USD

Biogen Inc. logo

Biogen Inc.

BIIB

165.79 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)